Navigation Links
Research shows cord blood comparable to matched bone marrow

University of Minnesota researchers report that umbilical cord blood transplants may offer blood cancer patients better outcomes than bone marrow transplants, according to an analysis of outcome data performed at the Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee.

This is the first study that directly compares matched bone marrow, which is currently considered the preferred graft, with matched and mismatched umbilical cord blood. There is considerable controversy in the medical community about which source of blood stem cells (cord blood or marrow) should be considered the “gold standard” for treatment of childhood leukemia.

In this study, the investigators compared outcomes of pediatric leukemia patients who received unrelated bone marrow transplants with those who received umbilical cord transplants. While all bone marrow donors were matched, nearly all cord blood donors were mismatched.

The main objective of the research was to compare the results after cord blood and marrow transplantation and provide guidelines to transplant physicians on the selection of the best donor for children with leukemia. Remarkably, mismatched cord blood performed as well as matched bone marrow as measured by leukemia-free survival rates, providing the degree of mismatch was limited and the number of cord blood cells available was sufficient. Furthermore, study participants who received matched cord blood had a 20 percent higher survival rate than matched bone marrow recipients, though the number of matched cord blood transplants was small.

The research appears in the June 9, 2007, issue of The Lancet with John E. Wagner, M.D., professor of Pediatrics and director of the University of Minnesota Medical School’s division of Pediatric Hematology/Oncology and Bone Marrow Transplantation, as senior investigator.

The study was done in collaboration with the National Cord Bl
'"/>

Source:University of Minnesota


Page: 1 2 3

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. Research advances quest for HIV-1 vaccine
6. Research on Worms Yields Clues on Aging
7. Researchers reveal the infectious impact of salmon farms on wild salmon
8. Researchers identify target for cancer drugs
9. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism

Post Your Comments:
(Date:11/23/2009)... , CINCINNATINew research presents strong evidenc...sure to both outdoor traffic-related pollution and...ungs than one or the other exposure alone. , E...f Cincinnati (UC) College of Medicine have shown t...c-related particles and indoor endotoxin during ea...
(Date:11/23/2009)... , TORONTO, November 23, 2009 - The time of day...ording to a new paper produced by a research team ...oronto Scarborough,s vice-principal for research a...s biology at the St. George campus. , Capitali...f the poplar tree, the research team examined how ...
(Date:11/23/2009)... , Farmington, CT Current research suggests that... disease. The related report by Nichols et al, "U...nt a New Class of TLR2 Ligands Capable of Enhancin...e of The American Journal of Pathology . , Mult...stem attacks the brain and spinal cord, affects ne...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 1Diabetes drug kills cancer stem cells in combination treatment in mice 9909 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 3Alert status area in brain discoved by Hebrew University scientists 9907 1Alert status area in brain discoved by Hebrew University scientists 9907 2Translational Research 3A From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 57026 1Translational Research 3A From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 57026 2
...oth pass on "traditions" to other members of their...ng behaviour. The findings add to evidence that cu...e study involved killerwhales at Marineland in Nia...evised a brand new way to catch birds, and passed ...orca lures gulls into his tank by spitting regurgi...
...ribed to patients with the common cold because the...nd the benefits do not outweigh the risks, accordi... , "Antibiotics appear to have no benefit in the t...ns," conclude Dr. Bruce Arroll and Dr. Timothy Ken...The implications for practice are that prescriptio...
...ands of biologists around the globe run DNA sequen...nline algorithm called BLAST ?typically submitting...de, to be matched against the billions of letters ...an shed light on functional or evolutionary relati...hrough and produce vast amounts of data. Everyday ...
Other Biology News:More animals join the learning circle 2Doctors should stop prescribing antibiotics for the common cold, review advises 2Drawing with DNA: 'Bioart' illuminates genomics 2Drawing with DNA: 'Bioart' illuminates genomics 3
(Date:11/24/2009).... , Whether it,s CD packaging, containers or...Identification) are increasingly finding their way...l objects or goods and identify them automatically...ead and process the data contained in the label. S...on conditions of up to 100 degrees Celsius. But at...
(Date:11/24/2009)...nvestment bank KTA Capital,s client Neuren Pharmac...nvertible note private placement with a U.S. insti...ged by KTA Capital as Neuren,s exclusive placement... York (PRWEB) November 23, 2009 -- The independent...KTA Capital") has announced that its client N...
(Date:11/24/2009)...ewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: D...NasdaqStockMarketthattradinginthecompany,scommonst...SEwillbefiledwiththe,SecuritiesandExchangeCommissi...nNasdaq,unlessthecompanyfilesanappealtotheNasdaq,L...appeal,which,willstaythesuspensionanddelistingthro...
(Date:11/24/2009)...ewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: D..."motionsbytheU.S.BankruptcyCourtfortheDistrictofDe...voluntarypetitionfor,reliefunderChapter11oftheUnit..., TheordersissuedbytheBankruptcyCourtallowthecom...r11proceedings.Inparticular,the,companyreceivedint...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...armaceuticals, the proprietary products division o...Companies, Inc. (NYSE: PRX ) today,announced that... Inc.,(Amex: IMM ) has chosen to discontinue the ...nvestigative therapy., On February 22, 2008, Immt...rts of adverse events related to abnormal kidney f...
...agene Inc., a,biotechnology company that develops ... announced today that one of the Nature Research,J...he FACTORIAL(TM). In,advance online publication on...colleagues describes a novel and remarkably consis...tivity of a large panel of transcription,factors.,...
...l/ - Oncothyreon Inc. (Nasdaq,- ONTY) (TSX - ONY) ...f,data demonstrating the effectiveness of PX-478 i...8th Annual Targeted Therapies of the Treatment of,...on for the Study of Lung,Cancer in Santa Monica, C...2008, by Jorg J. Jacoby, Ph.D., Instructor, Univer...
Other Biology Technology:Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 2Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 3Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 2Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 3Oncothyreon's PX-478 is effective in preclinical model of human lung cancer 2Oncothyreon's PX-478 is effective in preclinical model of human lung cancer 3
DHFR-1 FP-1 Forward Sequencing Primer from EPICENTRE Biotechnologies
Human Mesenchymal Stem Cell Functional Identification Kit from R&D Systems
Rabbit Anti-Syntrophin alpha 1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human HLA Class 1 A25 Monoclonal Antibody, Unconjugated, Clone 4i97 from Abcam
Biology Products: